10 BÜCHER, DIE MIT «DEAMINASE» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
deaminase in der folgenden bibliographischen Auswahl. Bücher, die mit
deaminase im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
1
1-Aminocyclopropane-1-carboxylate (ACC)
Deaminase Genes in ...
A collection of 233 putative Rhizobia strains from 30 different sites across Saskatchewan, Canada was assayed for ACC deaminase activity, with 27 of the strains displaying activity.
Jin Duan, University of Waterloo. Department of Biology, 2007
2
Case Studies in Immunology Fifth Edition: Activation-induced ...
... female normalfemale normal male proposita Fig. 12.1 A pedigree. Activation-
induced. Cytidine. Deaminase. (AID). Deficiency. Fig. 12.4 Histology of a lymph
node from a patient. 1 Activation-induced Cytidine Deaminase (AID) Deficiency.
Raif Geha, FRED Rosen, 2010
3
The Role of Virus Induced Activation Induced Cytidine ...
Epstein-Barr virus (EBV) infection of B lymphocytes induces the expression of
activation-induced cytidine deaminase (AID). UARP 20th AIDS Investigator's
Meeting. Los Angeles, California. (Abstract). Epeldegui M, Breen EC, McQuay A,
...
4
Ethylene: Agricultural Resources and Applications
ACC Deminase The enzyme, ACC deaminase which has been found only in
microorganisms, catalyses ACC to NHi and a-ketobutyrate as shown in Fig. 3.3 (
Penrose and Glide, 1997). This enzyme was first discovered in 1978 and was ...
Muhammad Arshad, William T. Frankenberger Jr., 2002
5
Class 3.5. - 3.12 Hydrolases X: EC 3.5.4 - 3.12.1
[16 [17 [18 [19 [20 [21 [22 [23 [24 [25 [26 [27 [28 [29 [30 [31 [32 Hunt, III, S.W.;
Hoffee, P.A.: Adenosine deaminase from deoxycoformycin- sensitive and -
resistent rat hepatoma cells. J. Biol. Chem., 257, 14239-14244 (1982) Lewis, A.S.
; ...
Dietmar Schomburg, Ida Schomburg, A. Chang, 2003
6
The Description, Prediction and Misprediction of Protein ...
... Q3VZ32 9ACTO Accession >gnl|tr|Q4NIH8_9MICC (Q4NIH8) Adenosine
deaminase precursor (EC 3.5.4.4) >gnl|tr|Q4LQ39_9BURK (Q4LQ39) Adenosine
deaminase (EC 3.5.4.4) >gnl|tr|Q4LHN2_9BURK (Q4LHN2) Adenosine
deaminase ...
Alexandra Maria Schnoes, 2008
7
Primary Immunodeficiency Diseases : A Molecular & Cellular ...
Spontaneous in vivo reversion to normal of an inherited mutation in a patient with
adenosine deaminase deficiency. Nat Genet 13:290–295, 1996. Hoogerbrugge
PM, van Beusechem VW, Fischer A, Debree M, Le Deist F, Perignon JL, Morgan
...
Department of Pediatrics University of Washington School of Medicine Hans D. Ochs Professor, Seattle, Center for Biotechnology C. I. Edward Smith Division of Clinical Immunology at Huddinge Hospital, Immunologic Genetics Section Jennifer M. Puck Director, Genetics and Molecular Biology Branch National Human Genome Research Institute National Instit, 2006
8
Plant Surface Microbiology
Since then,ACC deaminase has been detected in the fungus, Penicillium citrinum
(Honma 1993) and in a number of other bacterial strains (Klee and Kishore 1992;
Jacobson et al. 1994, Glick et al. 1995; Campbell and Thomson 1996) all of ...
Ajit Varma, Rüdiger Hampp, Dietrich Werner, 2007
9
Atlas of Metabolic Diseases Second edition
Combined immunodeficiency disease associated with adenosine deaminase
deficiency an inborn error of metabolism. Pediatr Res 1973;7:362. 4 Giblett ER,
Ammann AJ, Wara DW, etal. Nucleoside-phosphorylase deficiency in a child with
...
William L Nyhan, Bruce A Barshop, Pinar T. Ozand, 2005
10
Neuromuscular Disorders of Infancy, Childhood, and ...
6. Fishbein WN: Primary, secondary, and coincidental types of myoadenylate
deaminase deficiency (letter). Ann Neurol 45:547-548, 1999. 7. Shumate JB,
Katnik R, Ruiz M, et al: Myoadenylate deaminase deficiency. Muscle Nerve 2:213
-216, ...
H. Royden Jones, Darryl C. De Vivo, Basil T. Darras, 2003
10 NACHRICHTEN, IN DENEN DER BEGRIFF «DEAMINASE» VORKOMMT
Erfahre, worüber man in den einheimischen und internationalen Medien spricht und wie der Begriff
deaminase im Kontext der folgenden Nachrichten gebraucht wird.
Measles Virus Defective Interfering RNAs Are Generated Frequently …
Sequences flanking these mutation sites were characteristic of those favored by adenosine deaminase acting on RNA-1 (ADAR1), which ... «Journal of Virology, Jul 15»
Error correction and statistical analyses for intra-host comparisons of …
We also queried the data for cytidine deaminase activity on the viral genome, which causes an asymmetric increase in G to A substitutions, but ... «7thSpace Interactive, Jun 15»
Targeting by quartets
Such G4 RNA is recognized at nanomolar concentrations by AID, the cytidine deaminase that directs CSR. Substitution of the conserved ... «Nature.com, Jun 15»
Human dCTP pyrophosphatase 1 promotes breast cancer cell …
Article | PubMed | ISI | CAS |; Wang L, Weiss B. dcd (dCTP deaminase) gene of Escherichia coli: mapping, cloning, sequencing, and ... «Nature.com, Jun 15»
Preclinical Data At ADA Supports Development Of AntriaBio's …
... anti-VEGF aptamer (Pfizer's Macugen), alpha-interferon (Merck's PEGintron, Roche's Pegasys), adenosine deaminase (Enzon's Adagen), ... «Seeking Alpha, Jun 15»
4 Hot Stocks Under Consideration: Chesapeake Energy Corporation …
These ASHE subjects have a defined mutation in the porphobilinogen deaminase (PBGD) gene and elevated urinary levels of aminolevulinic ... «wsnewspublishers, Jun 15»
Harnessing the Immune System to Combat Aggressive Brain Tumors
... DNX-2401, measles virus, Toca 511 (a retroviral replicating vector that expresses the cytosine deaminase gene) and herpes simplex virus. «U.S. News & World Report, Jun 15»
Research and Markets: Global Gene Therapy 2015 - Technologies …
A further setback was the reports of leukemia following use of retroviral vectors in successful gene therapy for adenosine deaminase deficiency. «Digital Journal, Mai 15»
Alnylam Initiates Phase 1 Clinical Trial for ALN-AS1, an …
These ASHE subjects have a defined mutation in the porphobilinogen deaminase (PBGD) gene and elevated urinary levels of aminolevulinic ... «MarketWatch, Mai 15»
Money Flows Again to Gene-Therapy Drugs Investors Once Shunned
On May 5, GlaxoSmithKline Plc applied for approval in Europe for its first gene-therapy treatment, for a condition called adenosine deaminase ... «Bloomberg, Mai 15»
